Proposed LCD DL40187: MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis — Palmetto GBA
Policy LCD-DL40187 · Gastroenterology
New LCD for biomarker testing in liver disease proposed.